Cell Therapeutics, Inc. (NASDAQ: CTICD) surged more than 11% after the company announced that it will meet with the U.S. Food and Drugs Administration's Office of Oncology Drug Products in early June to discuss the re-submission of CTI's New Drug Application for pixantrone for accelerated approval to treat patients with relapsed or refractory aggressive non-Hodgkin's lymphoma. This meeting follows CTI's receipt of the FDA's Office of New Drugs' response to CTI's appeal as announced on May 3, 2011, which allows CTI the opportunity to resubmit the NDA to the FDA with additional information for consideration of accelerated approval of the NDA based on the PIX 301 trial. In the FDA's response to CTI's appeal, the FDA requested that CTI submit two items--an additional review of radiographs by an independent panel and additional information regarding circumstances of stopping the clinical trial prior to achieving the planned accrual to assure reviewers that efficacy assessments were not involved in the decision to stop accrual early.
CF Industries Holdings, Inc. (NYSE: CF) rallied as much as 6% after JP Morgan upgraded its rating on the company to Overweight from Neutral.
Cheniere Energy Partners, L.P. (AMEX: LNG) soared more than 17% after the company announced that on May 20, 2011, its subsidiary, Sabine Pass Liquefaction, LLC, received an order from the U.S. Department of Energy with authorization to export domestically produced natural gas from the Sabine Pass LNG terminal as liquefied natural gas ("LNG") to any country that has, or in the future develops, the capacity to import LNG and with which trade is permissible. This order expands upon the authorization Sabine Liquefaction received in September 2010, which authorized the exports of natural gas as LNG to all current and future Free Trade Agreement countries, and concludes one of the key regulatory requirements necessary for the Sabine Pass liquefaction expansion project.
Shares of Charming Shoppes (NASDAQ: CHRS) rose more than 4% after Bloomberg reported that the company is exploring a sale of Fashion Bug. Sources say the company is working with Moelis on a possible sale.
Identive Group, Inc. (Nasdaq: INVE) jumped more than 12% after the company announced that it has signed a Value Added Reseller agreement with NXP Semiconductors (Nasdaq: NXPI), under which the companies will work together to identify and address emerging opportunities in the secure identification market by promoting and selling Identive's identification products, based on NXP's RFID semiconductor technology.
Full Disclosure: None.
